Assessment of multiple sampling strategies to estimate SARS-CoV-2 epidemiological parameters

A recent study posted to the medRxiv* pre-print server estimated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemiological parameters by using various sampling strategies on the sequencing data of viral genomes.

Study: Using multiple sampling strategies to estimate SARS-CoV-2 epidemiological parameters from genomic sequencing data. Image Credit: CROCOTHERY/ShutterstockStudy: Using multiple sampling strategies to estimate SARS-CoV-2 epidemiological parameters from genomic sequencing data. Image Credit: CROCOTHERY/Shutterstock

Emerging SARS-CoV-2 variants of concern (VOCs) are extensively studied by analyzing viral genome sequences. This sequencing data is crucial to understanding the genetic variation in different VOCs, the difference in transmissibility of the VOCs, and their impact on disease severity and related hospitalizations. Epidemiological information obtained from genomic data can be utilized to facilitate better handling of the coronavirus disease 2019 (COVID-19) pandemic.

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

About the study

The present study explored the effects of different sampling strategies on important epidemiological parameters obtained from genomic sequencing data of SARS-CoV-2.

They included data from the Amazonas region and Hong Kong and calculated empirical epidemiological parameters. The basic reproduction number (R0) was estimated in the two data sources using confirmed SARS-CoV-2 cases over time. Maximum likelihood methods were used to evaluate the number of confirmed cases in a week, which were then fitted to a susceptible-exposed-infectious-recovered (SEIR) model.

The time-varying or effective reproduction number (Rt) was estimated using the EpiFilter model which in turn employed a renewal transmission model that described the dependence of the number of new confirmed cases at time t on the Rt at time t.

EpiFilter utilized information available on past and future incidences to reduce the dependence on assumptions and was used as a reference for parameters derived from genomic data. The relationship between growth rate (rt) and Rt was used to estimate r.

Complete genomes of SARS-CoV-2 were collected, screened, and the sequences obtained for the two groups were aligned. In the aligned sequences, the last 50 base pairs (bp) and the first 130 bp were removed to eliminate any sequencing artifacts. The quality control of both datasets was conducted based on completeness, diversity, and ambiguity of bases in each sequence, and the eligible sequences were selected for the study.

The two datasets of the Amazonas and the Hong Kong regions were subclassified into samples collected per week following a temporal sampling scheme which was based on the quantity of confirmed SARS-CoV-2 cases that week. The sample schemes were characterized as uniform, proportional, and allowed reciprocal-proportional sampling with no application of a sampling strategy.      

Results

The study results showed that a sampling intensity of 11.6% and 2.4% was observed in the number of COVID-19 cases in Hong Kong and the Amazonas throughout the study period. The number of confirmed SARS-CoV-2 cases per week in Hong Kong and the Amazonas in the unsampled scheme was 117 and 196, and that in the proportional sampling scheme was 54 and 168, while the uniform sampling scheme had 79 and 150 cases, and the reciprocal-proportional sampling scheme had 84 and 67 confirmed cases, respectively.

The correlation between sampling dates and genetic divergence ranged from 0.36 to 0.52 for the Hong Kong group and from 0.13 to 0.20 for the Amazonas region, indicating a higher temporal signal in the Hong Kong region. The mean submission rate in Hong Kong was between 9.16x10-4 and 2.09x10-3 substitutions per site per year (s/s/y), with overlapping Bayesian credible intervals (BCIs) in the sampling schemes. Also, the gradient of the slope (clock rate) was similar to the root-to-tip regression estimations and the early approximations of the mean substitution rate of SARS-CoV-2.

Overlapped BCIs were observed in the sampling scheme in the Amazonas region with a mean substitution rate between 4.00 x 10-4 and 5.56 x 10-4 s/s/y which indicated that the sampling strategy did not affect the clock rate estimation. The value of R0 in the Hong Kong region and the Amazonas region was 2.17 and 3.67, respectively. In both the datasets, all of the sampling schemes had similar values of R0 indicating that R0 is independent of the changes in the sampling method.    

Conclusion

The study findings showed that values of Rt and rt are dependent on changes in the sampling schemes while values of R0 did not change according to the sampling strategies. In the Hong Kong subset, the proportional sampling scheme could predict the reduction in Rt due to the application of public restrictions and the following increase and decrease of Rt during the emergence of new variants of concern in the second wave.    

The researchers believe that temporal sampling strategies can help create a generalized sampling framework to obtain essential epidemiologic information from genomic datasets collected from around the globe. This study noted that surveillance and analysis of genomic information are crucial to the appropriate handling of the COVID-19 pandemic.

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Journal references:

Article Revisions

  • May 11 2023 - The preprint preliminary research paper that this article was based upon was accepted for publication in a peer-reviewed Scientific Journal. This article was edited accordingly to include a link to the final peer-reviewed paper, now shown in the sources section.
Susha Cheriyedath

Written by

Susha Cheriyedath

Susha is a scientific communication professional holding a Master's degree in Biochemistry, with expertise in Microbiology, Physiology, Biotechnology, and Nutrition. After a two-year tenure as a lecturer from 2000 to 2002, where she mentored undergraduates studying Biochemistry, she transitioned into editorial roles within scientific publishing. She has accumulated nearly two decades of experience in medical communication, assuming diverse roles in research, writing, editing, and editorial management.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Cheriyedath, Susha. (2023, May 11). Assessment of multiple sampling strategies to estimate SARS-CoV-2 epidemiological parameters. News-Medical. Retrieved on November 21, 2024 from https://www.news-medical.net/news/20220209/Assessment-of-multiple-sampling-strategies-to-estimate-SARS-CoV-2-epidemiological-parameters.aspx.

  • MLA

    Cheriyedath, Susha. "Assessment of multiple sampling strategies to estimate SARS-CoV-2 epidemiological parameters". News-Medical. 21 November 2024. <https://www.news-medical.net/news/20220209/Assessment-of-multiple-sampling-strategies-to-estimate-SARS-CoV-2-epidemiological-parameters.aspx>.

  • Chicago

    Cheriyedath, Susha. "Assessment of multiple sampling strategies to estimate SARS-CoV-2 epidemiological parameters". News-Medical. https://www.news-medical.net/news/20220209/Assessment-of-multiple-sampling-strategies-to-estimate-SARS-CoV-2-epidemiological-parameters.aspx. (accessed November 21, 2024).

  • Harvard

    Cheriyedath, Susha. 2023. Assessment of multiple sampling strategies to estimate SARS-CoV-2 epidemiological parameters. News-Medical, viewed 21 November 2024, https://www.news-medical.net/news/20220209/Assessment-of-multiple-sampling-strategies-to-estimate-SARS-CoV-2-epidemiological-parameters.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Mild COVID-19 disrupts brain connectivity and reduces memory function in adolescents and young adults